Algert Global’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
53,092
-296,612
| -85% | -$6.4M | 0.02% | 780 |
|
|
2025
Q1 | $5.81M | Sell |
349,704
-136,200
| -28% | -$2.26M | 0.14% | 223 |
|
|
2024
Q4 | $8.92M | Sell |
485,904
-63,552
| -12% | -$1.17M | 0.21% | 139 |
|
|
2024
Q3 | $8.45M | Buy |
549,456
+15,313
| +3% | +$236K | 0.23% | 112 |
|
|
2024
Q2 | $8.68M | Buy |
534,143
+179,799
| +51% | +$2.92M | 0.29% | 64 |
|
|
2024
Q1 | $6.55M | Buy |
354,344
+93,467
| +36% | +$1.73M | 0.26% | 96 |
|
|
2023
Q4 | $8.17M | Buy |
260,877
+149,343
| +134% | +$4.68M | 0.33% | 50 |
|
|
2023
Q3 | $2.32M | Buy |
111,534
+380
| +0.3% | +$7.92K | 0.11% | 313 |
|
|
2023
Q2 | $2.66M | Sell |
111,154
-30,510
| -22% | -$731K | 0.12% | 286 |
|
|
2023
Q1 | $2.67M | Sell |
141,664
-32,855
| -19% | -$618K | 0.13% | 248 |
|
|
2022
Q4 | $2.78M | Sell |
174,519
-3,193
| -2% | -$50.8K | 0.15% | 195 |
|
|
2022
Q3 | $2.91M | Buy |
177,712
+11,581
| +7% | +$189K | 0.18% | 162 |
|
|
2022
Q2 | $2.34M | Buy |
166,131
+62,079
| +60% | +$875K | 0.18% | 141 |
|
|
2022
Q1 | $2.52M | Buy |
104,052
+67,620
| +186% | +$1.64M | 0.17% | 157 |
|
|
2021
Q4 | $850K | Buy |
36,432
+16,370
| +82% | +$382K | 0.11% | 326 |
|
|
2021
Q3 | $333K | Buy |
+20,062
| New | +$333K | 0.04% | 718 |
|
|
2021
Q1 | – | Sell |
-6,897
| Closed | -$369K | – | 428 |
|
|
2020
Q4 | $369K | Hold |
6,897
| – | – | 0.11% | 268 |
|
|
2020
Q3 | $285K | Sell |
6,897
-5,040
| -42% | -$208K | 0.09% | 265 |
|
|
2020
Q2 | $579K | Sell |
11,937
-11,672
| -49% | -$566K | 0.2% | 166 |
|
|
2020
Q1 | $997K | Buy |
+23,609
| New | +$997K | 0.42% | 71 |
|
|
2019
Q4 | – | Sell |
-7,370
| Closed | -$265K | – | 374 |
|
|
2019
Q3 | $265K | Buy |
+7,370
| New | +$265K | 0.1% | 236 |
|